Riedl Stefan, Röhl Friedrich-Wilhelm, Bonfig Walter, Brämswig Jürgen, Richter-Unruh Annette, Fricke-Otto Susanne, Bettendorf Markus, Riepe Felix, Kriegshäuser Gernot, Schönau Eckhard, Even Gertrud, Hauffa Berthold, Dörr Helmuth-Günther, Holl Reinhard W, Mohnike Klaus
Division of Pediatric Pulmology, Allergology and Endocrinology, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
Department of Pediatrics, St. Anna Kinderspital, Medical University of Vienna, Vienna, Austria.
Endocr Connect. 2019 Feb 1;8(2):86-94. doi: 10.1530/EC-18-0281.
Congenital adrenal hyperplasia (CAH) due to CYP21A2 gene mutations is associated with a variety of clinical phenotypes (salt wasting, SW; simple virilizing, SV; nonclassical, NC) depending on residual 21-hydroxylase activity. Phenotypes and genotypes correlate well in 80-90% of cases. We set out to test the predictive value of CAH phenotype assignment based on genotype classification in a large multicenter cohort. A retrospective evaluation of genetic data from 538 CAH patients (195 screened) collected from 28 tertiary centers as part of a German quality control program was performed. Genotypes were classified according to residual 21-hydroxylase activity (null, A, B, C) and assigned clinical phenotypes correlated with predicted phenotypes, including analysis of Prader stages. Ultimately, concordance of genotypes with clinical phenotypes was compared in patients diagnosed before or after the introduction of nationwide CAH-newborn screening. Severe genotypes (null and A) correlated well with the expected phenotype (SW in 97 and 91%, respectively), whereas less severe genotypes (B and C) correlated poorly (SV in 45% and NC in 57%, respectively). This was underlined by a high degree of virilization in girls with C genotypes (Prader stage >1 in 28%). SW was diagnosed in 90% of screening-positive babies with classical CAH compared with 74% of prescreening patients. In our CAH series, assigned phenotypes were more severe than expected in milder genotypes and in screened vs prescreening patients. Diagnostic discrimination between phenotypes based on genotypes may prove overcome due to the overlap in their clinical presentations.
由于CYP21A2基因突变导致的先天性肾上腺皮质增生(CAH)与多种临床表型(失盐型,SW;单纯男性化型,SV;非经典型,NC)相关,这取决于残余的21-羟化酶活性。在80%-90%的病例中,表型和基因型有很好的相关性。我们着手在一个大型多中心队列中测试基于基因型分类的CAH表型判定的预测价值。对作为德国质量控制项目一部分从28个三级中心收集的538例CAH患者(195例经筛查)的遗传数据进行了回顾性评估。根据残余的21-羟化酶活性(无效型、A、B、C)对基因型进行分类,并将相关的临床表型与预测表型进行关联,包括普拉德分期分析。最终,比较了在全国范围内开展CAH新生儿筛查之前或之后确诊的患者中基因型与临床表型的一致性。严重基因型(无效型和A)与预期表型有很好的相关性(分别为97%和91%的失盐型),而不太严重的基因型(B和C)相关性较差(分别为45%的单纯男性化型和57%的非经典型)。C基因型女孩的高度男性化(28%的普拉德分期>1)突出了这一点。90%的筛查阳性的经典型CAH婴儿被诊断为失盐型,而筛查前患者的这一比例为74%。在我们的CAH系列中,对于较轻基因型以及筛查患者与筛查前患者,指定的表型比预期的更严重。由于临床表型存在重叠,基于基因型对表型进行诊断区分可能难以实现。